Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab

BACKGROUND: Asthma and bronchiectasis are different conditions that frequently coexist. The prevalence of bronchiectasis rises considerably in subjects with severe asthma (25%–51%). OBJECTIVE: We evaluated the clinical and biological efficacy of mepolizumab on our pilot population of severe uncontro...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpagnano, Giovanna E, Scioscia, Giulia, Lacedonia, Donato, Curradi, Giacomo, Foschino Barbaro, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407514/
https://www.ncbi.nlm.nih.gov/pubmed/30881051
http://dx.doi.org/10.2147/JAA.S196200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407514/
https://www.ncbi.nlm.nih.gov/pubmed/30881051
http://dx.doi.org/10.2147/JAA.S196200

Ejemplares similares